REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 53 filers reported holding REGULUS THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,103,000 | -12.1% | 158,977 | +10.5% | 0.00% | 0.0% |
| Q4 2015 | $1,255,000 | -26.3% | 143,931 | -44.8% | 0.00% | 0.0% |
| Q3 2015 | $1,704,000 | -46.7% | 260,655 | -10.7% | 0.00% | -50.0% |
| Q2 2015 | $3,198,000 | -76.1% | 291,890 | -63.1% | 0.00% | -75.0% |
| Q1 2015 | $13,390,000 | -0.4% | 790,424 | -5.7% | 0.01% | 0.0% |
| Q4 2014 | $13,447,000 | +1344600.0% | 838,403 | +419101.5% | 0.01% | – |
| Q3 2014 | $1,000 | 0.0% | 200 | +185.7% | 0.00% | – |
| Q2 2014 | $1,000 | -83.3% | 70 | -89.1% | 0.00% | – |
| Q3 2013 | $6,000 | +20.0% | 645 | +15.8% | 0.00% | – |
| Q2 2013 | $5,000 | – | 557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
| Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
| ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
| Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
| Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
| Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
| DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
| ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
| Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |